Sutro Biopharma, Inc 10-Q for FY2026 Q2
Sutro Biopharma, Inc. (STRO)
10-Q
2026-08-12
For: 2026-06-30
View Original
Added on
August 13, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on August 12, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $9.84M
- down 84.6% from $63.75M a year earlier
- Net loss
- $38.53M
- compared with a net loss of $11.5M a year earlier
- Diluted EPS
- -$2.33
- compared with -$1.35 a year earlier